MEBEVERINE - (First line)

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 135mg

Dosage:

1 tablet 3 times daily, preferably 20 minutes before meals.

HYOSCINE BUTYLBROMIDE

Important: Therapy notes

MHRA advice: Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease (February 2017) (www.gov.uk).

  • The oral formulation of hyoscine butylbromide is poorly absorbed and therefore is not recommended.

Important: Formulation and dosage details

Formulation:

Injection 20mg/mL

Dosage:

By intramuscular or slow intravenous injection, acute spasm and spasm in diagnostic procedures, 20mg repeated after 30 minutes if necessary (may be repeated more frequently in endoscopy).

Editorial Information

Document Id: F223